Prior Art Litigation Search in Copenhagen.

A prior art search Copenhagen litigation counsel can rely on has to fit the twin realities of the Danish capital — a specialised national court and a busy European one under the same roof. Copenhagen is the seat of the Sø- og Handelsretten (Maritime and Commercial High Court), which hears Danish patent disputes nationwide, and it also hosts the Copenhagen local division of the Unified Patent Court. Around both venues sits Medicon Valley, the cross-border Øresund life-science cluster that makes pharma, biotech and medtech the local litigation theme. PerspireIP builds invalidity-grade searches for the accused parties and counsel fighting those patents across Denmark, the EPO and the UPC.

Where a prior art search Copenhagen case is actually heard

Denmark channels its patent litigation into one specialised forum. The Sø- og Handelsretten (Maritime and Commercial High Court) in Copenhagen is the first-instance court for patent infringement and validity disputes, with nationwide jurisdiction; its judgments are appealed to the Supreme Court (Højesteret). Founded in 1861 and sitting at Amaliegade 35, it also handles trademark, design, marketing-practices and competition matters, so patent cases are decided by judges used to commercial and technical evidence. Wherever in Denmark a dispute arises, Copenhagen is the venue.

That concentration makes the prior art decisive. In a Danish nullity action the accused party asks the court to revoke the patent for lack of novelty or inventive step, and the outcome turns on what was publicly available before the priority date. Whether the fight is a defensive counterclaim to an infringement suit or a standalone revocation action, the invalidity search is the engine of the case — and the Sø- og Handelsretten expects it charted claim by claim.

• Sø- og Handelsretten — first-instance court for Danish patent infringement and validity, nationwide reach
• Højesteret (Supreme Court) — hears appeals from the Maritime and Commercial High Court
• EPO Opposition Division — central attack on a European patent within nine months of grant
• Unified Patent Court — revocation of unitary and non-opted-out European patents, with a local division in Copenhagen

The dual forum: Copenhagen’s UPC local division

Copenhagen is unusual because it offers two live patent forums in the same building. Since the Unified Patent Court opened on 1 June 2023, the Danish local division of the UPC has sat at the Sø- og Handelsretten’s address at Amaliegade 35, sharing premises and secretariat support with the national court. An accused party in a Copenhagen dispute may therefore find itself before the Danish court, the UPC local division, or both, depending on how the patent was designated and whether it was opted out.

Denmark’s place in the UPC is settled and deliberate. A national referendum on 25 May 2014 approved membership with 62.5% of the vote, and Denmark ratified the UPC Agreement on 20 June 2014 — the fifth state to do so. The Copenhagen local division hears infringement and, by counterclaim, revocation for European patents in force in Denmark. Because a standalone revocation action can instead go to the UPC Central Division, an accused party often has to choose its forum before it fixes its prior art strategy.

Medicon Valley: where Copenhagen’s patent fights come from

Copenhagen anchors Medicon Valley, the cross-border life-science cluster spanning eastern Denmark and southern Sweden (Skåne) across the Øresund. Linked physically by the Øresund Bridge since 2000 and institutionally by the Medicon Valley Alliance since 1997, the region holds roughly 3.9 million people, twelve universities, eight university hospitals and hundreds of life-science organisations. Its research areas of excellence — cancer, diabetes and reproduction — map directly onto the patents that end up in dispute.

The corporate base is exceptionally concentrated. Novo Nordisk — the diabetes and GLP-1 giant headquartered in Bagsværd, whose Copenhagen predecessor dates to 1923 — sits alongside Lundbeck, Genmab, Zealand Pharma, Bavarian Nordic, ALK-Abelló and LEO Pharma, with cleantech leaders such as Ørsted nearby. The result: Copenhagen patent disputes cluster around small molecules, formulations, biologics, peptides, medical devices and sequences — not consumer electronics — and the anticipating art lives in the scientific record more often than in a patent index.

Where pharma, biotech and medtech prior art lives

Life-science patents are anticipated in a different literature than software or mechanics. A great deal of the decisive art never appears in a patent database at all — it lives in the peer-reviewed journal record and in specialist compound, structure and sequence collections. A credible invalidity search for a Medicon Valley claim has to reach those sources and prove the public-availability date of each reference it relies on.

• Chemical Abstracts (CAS) and the peer-reviewed journal literature, where a synthesis, formulation or compound may first be disclosed
• Sequence and structure databases for biologics, peptides, antibodies and nucleic-acid claims — central to Genmab- and Novo-style subject matter
• Older and abandoned patent families, frequently argued as inventive-step (obviousness) combinations under EPO problem-and-solution
• Conference abstracts, clinical-trial records, theses and dated regulatory disclosures that predate the priority date

For a formulation, dosage-regimen or device claim the anticipating reference is often an older paper or a lapsed patent family, not the headline blockbuster. We treat dating as evidence to be proved — establishing that each reference was genuinely public before the priority date the claim actually relies on, so it survives cross-examination at the Sø- og Handelsretten or scrutiny at the EPO.

Danish nullity, EPO opposition or UPC revocation: three routes

An accused party in Copenhagen usually has more than one way to attack a patent, and the routes are not interchangeable. A Danish nullity action runs before the Sø- og Handelsretten and revokes only the Danish part of the patent. EPO opposition is a central attack: filed within nine months of grant, it can knock out the European patent in every designated state at once, decided on novelty and inventive step.

The Unified Patent Court adds a third route. A UPC revocation action — whether a counterclaim before the Copenhagen local division or a standalone claim in the Central Division — can kill a unitary patent, or a European patent that has not been opted out, across all participating states in one judgment. Which route to run depends on the designation, the opt-out status and the timing, but every route depends on the same thing.

That shared dependency is the prior art search Copenhagen counsel commissions. One rigorous, claim-by-claim invalidity search can feed a Danish nullity counterclaim, a nine-month EPO opposition and a UPC revocation at the same time, so the same evidence base works across every forum an accused infringer might face.

Language and cross-border scope across the Øresund

Copenhagen’s defining feature is that it is bilingual by design and cross-border by geography. The Sø- og Handelsretten works in Danish, while the Copenhagen UPC local division has designated Danish or English as its languages of proceedings, and the parties may agree — subject to the division’s approval — to run in French or German instead. Prior art and expert evidence therefore have to be usable in more than one language from the outset.

The language of the patent right itself matters too. Denmark is a London Agreement country: to validate a European patent it requires the claims in Danish and the description in English (or, where the patent was granted in French or German, an English or Danish translation of the specification), filed at the DKPTO within three months of grant. That means the operative claim wording an accused party must invalidate may exist in a Danish translation, while the underlying art spans Danish, English, German and Swedish sources across Medicon Valley.

Because the Øresund cluster straddles Denmark and Sweden, the same patent family is often asserted on both sides of the strait and before the UPC. We build invalidity evidence that travels — robust across jurisdictions and languages — so a reference that anticipates a claim in Copenhagen also carries weight in an EPO opposition or a parallel Swedish or UPC proceeding.

How PerspireIP builds a prior art search Copenhagen case can rely on

Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the priority date that actually governs each one, and search against that date rather than the filing date on the cover. For pharma, biotech and medtech subject-matter we run patent and deep non-patent-literature searching in parallel — CAS, journals, sequence and structure databases — then build claim charts a Danish judge, an EPO Opposition Division or a UPC panel can follow.

• Claim charting mapped to novelty and inventive step under the EPC and Danish patent law
• Deep retrieval across CAS, peer-reviewed journals, sequence and structure databases and older patent families
• Public-availability dating for every reference, evidenced across Danish, English, German and Swedish sources
• Prior art sized to your forum — a Sø- og Handelsretten nullity action, the nine-month EPO opposition window, or UPC revocation
• A written invalidity analysis and reference packages ready for the Danish court, the EPO or the UPC

We work alongside your Danish and European counsel as a specialist search partner, deliver to Copenhagen, EPO and UPC deadlines, and keep every engagement confidential. Whether you are a Medicon Valley manufacturer facing an assertion, a generics or biosimilar entrant clearing a path, or litigation counsel preparing a cross-border defence, we scale to fit — a single search, a multi-patent campaign or ongoing support. Send us the patent number and your key dates, and we will scope a prior art search Copenhagen project within one business day.

IP Landscape & Resources in Copenhagen

Key intellectual-property authorities and venues relevant to Copenhagen:

• Danish Patent and Trademark Office (DKPTO) — the Danish patent office (Patent- og Varemærkestyrelsen); grants Danish patents and handles validation of European patents in Denmark
• Sø- og Handelsretten (Maritime and Commercial High Court) — the specialised Copenhagen court with nationwide jurisdiction over Danish patent infringement and validity disputes
• European Patent Office (EPO) — grants European patents and runs post-grant opposition, a central attack filed within nine months of grant
• Unified Patent Court (UPC) — hears infringement and revocation of unitary and non-opted-out European patents; a local division sits in Copenhagen

Request a Prior Art Search in Copenhagen

Explore related PerspireIP services: Prior Art Litigation Search · Patent Invalidation · Patent Infringement Analysis.

Frequently Asked Questions